M
M2M PHARMACEUTICALS LTD
Having a rich knowledge and decades of experience, especially in the solid-state analysis, the intention was to set M2M pharma as a company of choice for Material Characterisation with a special emphasis on developing methods for quantifying the small level of amorphous content in micronized samples. Today, we have all in-house technology that is running, with a principle to cGMP quality system, and supporting our clients regularly. A pharmaceutical scientist with a PhD in Pharmaceutics. Prior to setting up M2M Pharmaceuticals Ltd., Mridul had worked for a CRO for 12 years in early-stage product development especially related to material science for respiratory drug delivery. In his professional career, he had worked in principles to GMP as per the ICH Q8 and Q10, and well trained with Q7, Q9, and Q11. Mridul is a Fellow of Royal Society of Chemistry (FRSC), Member of Academy of Pharmaceutical Sciences (MAPS), Focus Group Member for Material Science at APS, Member of Aerosol Society, UK. Mridul is an Honorary Lecturer at UCL School of Pharmacy, London. We are immensely proud to have invaluable contacts within academia, industries and together we are providing a personalised and comprehensive solutions to the challenges our customers are facing every day. Our clients include start-up, virtual, spin out to major multinational companies from all over the world. We provide services to Pharmaceutical, Biotechnological, Biological, Food, Consumer Products, Cosmetics, Agricultural, Construction industries etc. We have a State-of-the-art laboratory facility at the brand-new Thames Valley Science Park (TVSP) in Reading, UK. TVSP is an easy access site; located on M4 corridor between J10 and J11, which is just 25 miles from Heathrow Airport and 40 miles from central London.
Country/Area ：United Kingdom
Company Email ：info@m2mpharma.com
Industry ：Manufacturing GeneralManufacturing
Company website ：*****
Company phone ：+44 1183041035
Established ：2016-01-29
Company Revenue ：$969,000
Number of employees ：1-10
SIC Code ：28283
NAICS Code ：32325
Web Summary
Q1: What is the address of M2M Pharmaceuticals Ltd?
A1: The exact address of M2M Pharmaceuticals Ltd is not explicitly mentioned in the provided content, but it can be inferred that they are based in the UK, as indicated by the phone number and email address.
Q2: What products or services does M2M Pharma offer?
A2: M2M Pharma offers a range of services including Physical Characterisation Services, Early Stage Product Development, Consultancy, Independent Laboratory Services for Patent and Litigation Issues, and Expert Witness. They also provide product development support, including identifying the path to growth and crafting a plan to take clients there.
Q3: What is the industry or sector that M2M Pharma operates in?
A3: The provided content does not explicitly state the industry or sector of M2M Pharma, but based on their services and expertise, it can be inferred that they operate in the pharmaceutical industry, specifically in the area of drug development and quality control.
Q4: What is the contact information for M2M Pharma?
A4: The contact information provided includes a phone number (+44 (0) 7946 560263), an email address (mridul.majumder@m2mpharma.com), and a website URL (www.m2mpharma.com).
Q5: What is the company's approach to quality control?
A5: According to the provided content, M2M Pharma's approach to quality control is centered around ensuring that quality is maintained, simple, flexible, productive, on-time delivery, and cost-effective. They also emphasize the importance of expert data interpretation and have a strong track record of handling 1000s of batches across various APIs.
Q6: What techniques does M2M Pharma use for amorphous content determination?
A6: The provided content mentions that M2M Pharma has developed numerous methods using Gas Perfusion Microcalorimetry (GPµC) over the last two decades. They also have expertise in using DVS-Advantage and other specialized techniques, such as Multi-Channel Solution Calorimetry (TAM2277).
Q7: What awards or recognitions has M2M Pharma received?
A7: According to the provided content, M2M Pharma was awarded The King's Award for Enterprise 2024 in International Trade, which is a remarkable achievement for the company that was founded in 2016.
Q8: What new developments or milestones has M2M Pharma achieved recently?
A8: The provided content mentions that M2M Pharma opened a brand-new site with a fitted laboratory in December 2022, which includes a Material Science Lab and Product Development lab. They also installed new equipment, such as Raman (RA802 from Renishaw) chemical imaging and the MASTERSIZER 3000 with dry and wet dispersions, in previous years.
A1: The exact address of M2M Pharmaceuticals Ltd is not explicitly mentioned in the provided content, but it can be inferred that they are based in the UK, as indicated by the phone number and email address.
Q2: What products or services does M2M Pharma offer?
A2: M2M Pharma offers a range of services including Physical Characterisation Services, Early Stage Product Development, Consultancy, Independent Laboratory Services for Patent and Litigation Issues, and Expert Witness. They also provide product development support, including identifying the path to growth and crafting a plan to take clients there.
Q3: What is the industry or sector that M2M Pharma operates in?
A3: The provided content does not explicitly state the industry or sector of M2M Pharma, but based on their services and expertise, it can be inferred that they operate in the pharmaceutical industry, specifically in the area of drug development and quality control.
Q4: What is the contact information for M2M Pharma?
A4: The contact information provided includes a phone number (+44 (0) 7946 560263), an email address (mridul.majumder@m2mpharma.com), and a website URL (www.m2mpharma.com).
Q5: What is the company's approach to quality control?
A5: According to the provided content, M2M Pharma's approach to quality control is centered around ensuring that quality is maintained, simple, flexible, productive, on-time delivery, and cost-effective. They also emphasize the importance of expert data interpretation and have a strong track record of handling 1000s of batches across various APIs.
Q6: What techniques does M2M Pharma use for amorphous content determination?
A6: The provided content mentions that M2M Pharma has developed numerous methods using Gas Perfusion Microcalorimetry (GPµC) over the last two decades. They also have expertise in using DVS-Advantage and other specialized techniques, such as Multi-Channel Solution Calorimetry (TAM2277).
Q7: What awards or recognitions has M2M Pharma received?
A7: According to the provided content, M2M Pharma was awarded The King's Award for Enterprise 2024 in International Trade, which is a remarkable achievement for the company that was founded in 2016.
Q8: What new developments or milestones has M2M Pharma achieved recently?
A8: The provided content mentions that M2M Pharma opened a brand-new site with a fitted laboratory in December 2022, which includes a Material Science Lab and Product Development lab. They also installed new equipment, such as Raman (RA802 from Renishaw) chemical imaging and the MASTERSIZER 3000 with dry and wet dispersions, in previous years.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
